Optical Coherence Tomography Angiography in Neurodegenerative Diseases: A Review

References

• Roisman L, Goldhardt R. OCT angiography: an upcoming non-invasive tool for diagnosis of age-related macular degeneration. Curr Ophthalmol Rep. 2017;5:136–140. doi:10.1007/s40135-017-0131-629051844
   PubMedGoogle Scholar
• Balaratnasingam C, Yannuzzi LA, Spaide RF. Possible choroidal neovacularization in macular telangiectasia type 2. Retina. 2015;35:2317–2322. doi:10.1097/IAE.000000000000088726465619
   PubMed Web of Science ®Google Scholar
• Coscas F, Glacet-Bernard A, Miere A, et al. Optical coherence tomography angiography in retinal vein occlusion: evaluation of superficial and deep capillary plexa. Am J Ophthalmol. 2016;161:160–167. doi:10.1016/j.ajo.2015.10.00826476211
   PubMed Web of Science ®Google Scholar
• Wakabayashi T, Sato T, Hara-Ueno C, et al. Retinal microvasculature and visual acuity in eyes with branch retinal vein occlusion: imaging analysis by optical coherence tomography angiography. Invest Opthalmol Vis Sci. 2017;58:2087. doi:10.1167/iovs.16-21208
   Web of Science ®Google Scholar
• Spaide RF. Volume-rendered optical coherence tomography of diabetic retinopathy pilot study. Am J Ophthalmol. 2015;160:1200–1210. doi:10.1016/j.ajo.2015.09.01026384548
   PubMed Web of Science ®Google Scholar
• Jia Y, Wei E, Wang X, et al. Optical coherence tomography angiography of optic disc perfusion in glaucoma. Ophthalmology. 2014;121(7):1322–1332. doi:10.1016/j.ophtha.2014.01.02124629312
   PubMed Web of Science ®Google Scholar
• Wang L, Murphy O, Caldito NG, Calabresi PA, Saidha S. Emerging applications of Optical Coherence Tomography Angiography (OCTA) in neurological research. Eye Vis. 2018;5:11. doi:10.1186/s40662-018-0104-3
   PubMedGoogle Scholar
• Carpineto P, Mastropasqua R, Marchini G, Toto L, Di Nicola M, Di Antonio L. Reproducibility and repeatability of foveal avascular zone measurements in healthy subjects by optical coherence tomography angiography. Br J Ophthalmol. 2016;100:671–676. doi:10.1136/bjophthalmol-2015-30733026377414
   PubMed Web of Science ®Google Scholar
• Hwang TS, Jia Y, Gao SS, et al. Optical coherence tomography angiography features of diabetic retinopathy. Retina. 2015;35(11):2371–2376. doi:10.1097/IAE.000000000000071626308529
   PubMed Web of Science ®Google Scholar
• Matsunaga D, Yi J, Puliafito CA, Kashani AH. OCT angiography in healthy human subjects. Ophthalmic Surg Lasers Imaging Retina. 2014;45:510–515. doi:10.3928/23258160-20141118-0425423629
   PubMed Web of Science ®Google Scholar
• Stanga PE, Lim JI, Hamilton P. Indocyanine green angiography in chorioretinal diseases: indications and interpretation: an evidence-based update. Ophthalmology. 2003;110(1):15–21. doi:10.1016/S0161-6420(02)01563-412511340
   PubMed Web of Science ®Google Scholar
• Ito YN, Mori K, Young-Duvall J, Yoneya S. Aging changes of the choroidal dye filling pattern in indocyanine green angiography of normal subjects. Retina. 2001;21(3):237–242. doi:10.1097/00006982-200106000-0000711421013
   PubMed Web of Science ®Google Scholar
• Teussink MM, Breukink MB, van Grinsven MJ, et al. OCT angiography compared to fluorescein and indocyanine green angiography in chronic central serous chorioretinopathy. Invest Ophthalmol Vis Sci. 2015;56:5229–5237. doi:10.1167/iovs.15-1714026244299
   PubMed Web of Science ®Google Scholar
• London A, Benhar I, Schwartz M. The retina as a window to the brain-from eye research to CNS disorders. Nat Rev Neurol. 2013;9:44–53. doi:10.1038/nrneurol.2012.22723165340
   PubMed Web of Science ®Google Scholar
• Patton N, Aslam T, Macgillivray T, Pattie A, Deary IJ, Dhillon B. Retinal vascular image analysis as a potential screening tool for cerebrovascular disease: a rationale based on homology between cerebral and retinal microvasculatures. J Anat. 2005;206(4):319–348. doi:10.1111/j.1469-7580.2005.00395.x15817102
   PubMed Web of Science ®Google Scholar
• Wang RK, Hurst S. Mapping of cerebro-vascular blood perfusion in mice with skin and skull intact by optical micro-angioGraphy at 1.3 mum wavelength. Opt Express. 2007;15:11402–11412. doi:10.1364/OE.15.01140219547498
   PubMed Web of Science ®Google Scholar
• Wang X, Jia Y, Spain R, et al. Optical coherence tomography angiography of optic nerve head and parafovea in multiple sclerosis. Br J Ophthalmol. 2014;98:1368–1373. doi:10.1136/bjophthalmol-2013-30454724831719
   PubMed Web of Science ®Google Scholar
• Feucht N, Maier M, Lepennetier G, et al. Optical coherence tomography angiography indicates associations of the retinal vascular network and disease activity in multiple sclerosis. Mult Scler. 2019;25:224–234. doi:10.1177/135245851775000929303033
   PubMed Web of Science ®Google Scholar
• Lanzillo R, Cennamo G, Criscuolo C, et al. Optical coherence tomography angiography retinal vascular network assessment in multiple sclerosis. Mult Scler. 2018;24:1706–1714. doi:10.1177/135245851772946328933233
   PubMed Web of Science ®Google Scholar
• Spain RI, Liu L, Zhang X, et al. Optical coherence tomography angiography enhances the detection of optic nerve damage in multiple sclerosis. Br J Ophthalmol. 2018;102:520–524. doi:10.1136/bjophthalmol-2017-31047728814415
   PubMed Web of Science ®Google Scholar
• Bulut M, Kurtuluş F, Gözkaya O, et al. Evaluation of optical coherence tomography angiographic findings in alzheimer’s type dementia. Br J Ophthalmol. 2018;102:233–237. doi:10.1136/bjophthalmol-2017-31047628600299
   PubMed Web of Science ®Google Scholar
• den Haan J, Janssen SF, van de Kreeke JA, Scheltens P, Verbraak FD, Bouwman FH. Retinal thickness correlates with parietal cortical atrophy in early-onset alzheimer’s disease and controls. Alzheimers Dement. 2017;10:49–55. doi:10.1016/j.dadm.2017.10.005
   Google Scholar
• Jiang H, Wei Y, Shi Y, et al. Altered macular microvasculature in mild cognitive impairment and alzheimer disease. J Neuroophthalmol. 2018;38:292–298. doi:10.1097/WNO.000000000000058029040211
   PubMed Web of Science ®Google Scholar
• Balducci N, Morara M, Veronese C, et al. Optical coherence tomography angiography in acute arteritic and non-arteritic anterior ischemic optic neuropathy. Graefes Arch Clin Exp Ophthalmol. 2017;255:2255–2261. doi:10.1007/s00417-017-3774-y28861697
   PubMed Web of Science ®Google Scholar
• Fard MA, Suwan Y, Moghimi S, et al. Pattern of peripapillary capillary density loss in ischemic optic neuropathy compared to that in primary open-angle glaucoma. PLoS One. 2018;13:e0189237. doi:10.1371/journal.pone.018923729320503
   PubMed Web of Science ®Google Scholar
• Ghasemi Falavarjani K, Tian JJ, Akil H, Garcia GA, Sadda SR, Sadun AA. Swept-source optical coherence tomography angiography of the optic disk in optic neuropathy. Retina. 2016;36(Suppl 1):S168–S177. doi:10.1097/IAE.000000000000125928005675
   PubMed Web of Science ®Google Scholar
• Ling JW, Yin X, Lu QY, Chen YY, Lu PR. Optical coherence tomography angiography of optic disc perfusion in non-arteritic anterior ischemic optic neuropathy. Int J Ophthalmol. 2017;10:1402–1406. doi:10.18240/ijo.2017.09.1228944200
   PubMed Web of Science ®Google Scholar
• Song Y, Min JY, Mao L, Gong YY. Microvasculature dropout detected by the optical coherence tomography angiography in nonarteritic anterior ischemic optic neuropathy. Lasers Surg Med. 2018;50:194–201. doi:10.1002/lsm.2271228986994
   PubMed Web of Science ®Google Scholar
• Zhang Q, Lee CS, Chao J, et al. Wide-field optical coherence tomography based microangiography for retinal imaging. Sci Rep. 2016;6:22017. doi:10.1038/srep2201726912261
   PubMed Web of Science ®Google Scholar
• Jia Y, Bailey ST, Hwang TS, et al. Quantitative optical coherence tomography angiography of vascular abnormalities in the living human eye. Proc Natl Acad Sci U S A. 2015;112(18):E2395–E2402. doi:10.1073/pnas.150018511225897021
   PubMed Web of Science ®Google Scholar
• Moussa M, Leila M, Khalid H, Lolah M. Detection of silent type I choroidal neovascular membrane in chronic central serous chorioretinopathy using en face swept-source optical coherence tomography angiography. J Ophthalmol. 2017;2017:6913980. doi:10.1155/2017/691398029348931
   PubMed Web of Science ®Google Scholar
• Zhang Q, Wang RK, Chen C-L, et al. Swept source optical coherence tomography angiography of neovascular macular telangiectasia type 2. Retina. 2015;35(11):2285–2299. doi:10.1097/IAE.000000000000084026457402
   PubMed Web of Science ®Google Scholar
• Miller AR, Roisman L, Zhang Q, et al. Comparison between spectral-domain and swept-source optical coherence tomography angiographic imaging of choroidal neovascularization. Invest Ophthalmol Vis Sci. 2017;58:1499–1505. doi:10.1167/iovs.16-2096928273316
   PubMed Web of Science ®Google Scholar
• Zhang Q, Huang Y, Zhang T, et al. Wide-field imaging of retinal vasculature using optical coherence tomography-based microangiography provided by motion tracking. J Biomed Opt. 2015;20:066008. doi:10.1117/1.JBO.20.6.06600826102573
   PubMed Web of Science ®Google Scholar
• Huang Y, Zhang Q, Thorell MR, et al. Swept-source OCT angiography of the retinal vasculature using intensity differentiation-based optical microangiography algorithms. Ophthalmic Surg Lasers Imaging Retina. 2014;45:382–389. doi:10.3928/23258160-20140909-0825230403
   PubMed Web of Science ®Google Scholar
• Munk MR, Giannakaki-Zimmermann H, Berger L, et al. OCT-angiography: a qualitative and quantitative comparison of 4 OCT-A devices. PLoS One. 2017;12(5):e0177059. doi:10.1371/journal.pone.017705928489918
   PubMed Web of Science ®Google Scholar
• Chen CL, Wang RK. Optical coherence tomography based angiography [Invited]. Biomed Opt Express. 2017;24(8):1056–1082. doi:10.1364/BOE.8.001056
   Web of Science ®Google Scholar
• de Carlo TE, Bonini Filho MA, Baumal CR, et al. Evaluation of preretinal neovascularization in proliferative diabetic retinopathy using optical coherence tomography angiography. Ophthalmic Surg Lasers Imaging Retina. 2016;47(2):115–119. doi:10.3928/23258160-20160126-0326878443
   PubMed Web of Science ®Google Scholar
• Dansingani KK, Freund KB. Optical coherence tomography angiography reveals mature, tangled vascular networks in eyes with neovascular age-related macular degeneration showing resistance to geographic atrophy. Ophthalmic Surg Lasers Imaging Retina. 2015;46:907–912. doi:10.3928/23258160-20151008-0226469229
   PubMed Web of Science ®Google Scholar
• Chen Z, Huang D, Izatt JA, et al. Volume-rendering optical coherence tomography angiography of macular telangiectasia type 2 (ophthalmology 2015;122:2261-9). Ophthalmology. 2016;123(3):e24. doi:10.1016/j.ophtha.2015.10.013
   Web of Science ®Google Scholar
• Yu J, Jiang C, Wang X, et al. Macular perfusion in healthy Chinese: an optical coherence tomography angiogram study. Invest Ophthalmol Vis Sci. 2015;56:3212–3217. doi:10.1167/iovs.14-1627026024105
   PubMed Web of Science ®Google Scholar
• Choi W, Mohler KJ, Potsaid B, et al. Choriocapillaris and choroidal microvasculature imaging with ultrahigh speed OCT angiography. PLoS One. 2013;8(12):e81499. doi:10.1371/journal.pone.008149924349078
   PubMed Web of Science ®Google Scholar
• Ikuta F, Zimmerman HM. Distribution of plaques in seventy autopsy cases of multiple sclerosis in the United States. Neurology. 1976;26(6 PT 2):26–28. doi:10.1212/WNL.26.6_Part_2.26944889
   PubMed Web of Science ®Google Scholar
• Toussaint D, Périer O, Verstappen A, Bervoets S. Clinicopathological study of the visual pathways, eyes, and cerebral hemispheres in 32 cases of disseminated sclerosis. J Clin Neuroophthalmol. 1983;3:211–220.6226722
   PubMedGoogle Scholar
• Saidha S, Al-Louzi O, Ratchford JN, et al. Optical coherence tomography reflects brain atrophy in multiple sclerosis: a four-year study. Ann Neurol. 2015;78:801–813. doi:10.1002/ana.2448726190464
   PubMed Web of Science ®Google Scholar
• Plumb J, McQuaid S, Mirakhur M, Kirk J. Abnormal endothelial tight junctions in active lesions and normal-appearing white matter in multiple sclerosis. Brain Pathol. 2002;12:154–169. doi:10.1111/j.1750-3639.2002.tb00430.x11958369
   PubMed Web of Science ®Google Scholar
• Doche E, Lecocq A, Maarouf A, et al. Hypoperfusion of the thalamus is associated with disability in relapsing remitting multiple sclerosis. J Neuroradiol. 2017;44:158–164. doi:10.1016/j.neurad.2016.10.00127865557
   PubMed Web of Science ®Google Scholar
• Narayana PA, Zhou Y, Hasan KM, Datta S, Sun X, Wolinsky JS. Hypoperfusion and T1-hypointense lesions in white matter in multiple sclerosis. Mult Scler. 2014;20:365–373. doi:10.1177/135245851349593623836878
   PubMed Web of Science ®Google Scholar
• Vos SJ, Verhey F, Frölich L, et al. Prevalence and prognosis of alzheimer’s disease at the mild cognitive impairment stage. Brain. 2015;138(Pt 5):1327–1338. doi:10.1093/brain/awv02925693589
   PubMed Web of Science ®Google Scholar
• Yamashita KI, Taniwaki Y, Utsunomiya H, Taniwaki T. Cerebral blood flow reduction associated with orientation for time in amnesic mild cognitive impairment and Alzheimer's disease patients. J Neuroimaging. 2014;24:590–594. doi:10.1111/jon.1209624593247
   PubMed Web of Science ®Google Scholar
• Snyder PJ, Johnson LN, Lim YY, et al. Nonvascular retinal imaging markers of preclinical Alzheimer’s disease. Alzheimers Dement. 2016;4:169–178.
   Google Scholar
• Garcia-Martin E, Bambo MP, Marques M, et al. Ganglion cell layer measurements correlate with disease severity in patients with alzheimer’s disease. Acta Ophthalmol. 2016;94(6):e454–e459. doi:10.1111/aos.1297726895692
   PubMed Web of Science ®Google Scholar
• Akbari M, Abdi P, Fard MA, et al. Retinal ganglion cell loss precedes retinal nerve fiber thinning in nonarteritic anterior ischemic optic neuropathy. J Neuroophthalmol. 2016;36:141–146. doi:10.1097/WNO.000000000000034526835663
   PubMed Web of Science ®Google Scholar
• Takayama K, Ito Y, Kaneko H, Kataoka K, Ra E, Terasaki H. Optical coherence tomography angiography in Leber hereditary optic neuropathy. Acta Ophthalmol. 2017;95:e344–e345. doi:10.1111/aos.1324427778481
   PubMed Web of Science ®Google Scholar
• Goldhagen BE, Bhatti MT, Srinivasan PP, Chiu SJ, Farsiu S, El-Dairi MA. Retinal atrophy in eyes with resolved papilledema detected by optical coherence tomography. J Neuroophthalmol. 2015;35:122–126. doi:10.1097/WNO.000000000000021025742060
   PubMed Web of Science ®Google Scholar
• Carta A, Mora P, Aldigeri R, et al. Optical coherence tomography is a useful tool in the differentiation between true edema and pseudoedema of the optic disc. PLoS One. 2018;13:e0208145. doi:10.1371/journal.pone.020814530496251
   PubMed Web of Science ®Google Scholar
• Mikelberg FS, Drance SM, Schulzer M, Yidegiligne HM, Weis MM. The normal human optic nerve: axon count and axon diameter distribution. Ophthalmology. 1989;96(9):1325–1328. doi:10.1016/S0161-6420(89)32718-72780002
   PubMed Web of Science ®Google Scholar
• Pan BX, Ross-Cisneros FN, Carelli V, et al. Mathematically modeling the involvement of axons in Leber’s hereditary optic neuropathy. Invest Ophthalmol Vis Sci. 2012;53(12):7608–7617. doi:10.1167/iovs.12-1045223060142
   PubMed Web of Science ®Google Scholar
• Fard M, Sahraiyan A, Jalil J, et al. Optical coherence tomography angiography in papilledema compared with pseudopapilledema. Invest Ophthalmol Vis Sci. 2019;60(1):168–175. doi:10.1167/iovs.18-2545330640969
   PubMed Web of Science ®Google Scholar
• Abcouwer SF, Gardner TW. Diabetic retinopathy: loss of neuroretinal adaptation to the diabetic metabolic environment. Ann N Y Acad Sci. 2014;1311::174–190. doi:10.1111/nyas.1241224673341
   PubMed Web of Science ®Google Scholar
• Simó R, Hernández C. Neurodegeneration in the diabetic eye: new insights and therapeutic perspectives. Trends Endocrinol Metab. 2014;25(1):23–33. doi:10.1016/j.tem.2013.09.00524183659
   PubMed Web of Science ®Google Scholar
• Simó R, Hernández C. Novel approaches for treating diabetic retinopathy based on recent pathogenic evidence. Prog Retin Eye Res. 2015;48:160–180. doi:10.1016/j.preteyeres.2015.04.00325936649
   PubMed Web of Science ®Google Scholar
• Stitt AW, Curtis TM, Chen M, et al. The progress in understanding and treatment of diabetic retinopathy. Prog Retin Eye Res. 2016;51:156–186. doi:10.1016/j.preteyeres.2015.08.00126297071
   PubMed Web of Science ®Google Scholar
• Simó R, Stitt AW, Gardner WT. Neurodegeneration in diabetic retinopathy: does it really matter? Diabetologia. 2018;61:1902–1912. doi:10.1007/s00125-018-4692-130030554
   PubMed Web of Science ®Google Scholar
• Hawkins BT, Davis TP. The blood-brain barrier/neurovascular unit in health and disease. Pharmacol Rev. 2005;57(2):173–185. doi:10.1124/pr.57.2.415914466
   PubMed Web of Science ®Google Scholar
• Antonetti DA, Klein R, Gardner TW. Diabetic retinopathy. N Engl J Med. 2012;366(13):1227–1239. doi:10.1056/NEJMra100507322455417
   PubMed Web of Science ®Google Scholar
• Gardner TW, Davila JR. The neurovascular unit and the pathophysiologic basis of diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol. 2017;255(1):1–6. doi:10.1007/s00417-016-3548-y27832340
   PubMed Web of Science ®Google Scholar
• Newman EA. Functional hyperemia and mechanisms of neurovascular coupling in the retinal vasculature. J Cereb Blood Flow Metab. 2013;33(11):1685–1695. doi:10.1038/jcbfm.2013.14523963372
   PubMed Web of Science ®Google Scholar
• Metea MR, Newmman EA. Signalling within the neurovascular unit in the retina. Exp Physiol. 2007;92:635–640. doi:10.1113/expphysiol.2006.03637617434916
   PubMed Web of Science ®Google Scholar
• Spaide RF, Fujimoto JG, Waheed NK, Sadda SR, Staurenghi G. Optical coherence tomography angiography. Prog Retin Eye Res. 2018;64:1–55. doi:10.1016/j.preteyeres.2017.11.00329229445
   PubMed Web of Science ®Google Scholar
• Hasegawa N, Nozaki M, Takase N, Yoshida OY. New insights into microaneurysms in the deep capillary plexus detected by optical coherence tomography angiography in diabetic macular edema. Invest Ophthalmol Vis Sci. 2016;57:OCT348–OCT355. doi:10.1167/iovs.15-1878227409492
   PubMed Web of Science ®Google Scholar
• Simó R, Ciudin A, Simó-Servat O, Hernández C. Cognitive impairment and dementia: a new emerging complication of type 2 diabetes—the diabetologist’s perspective. Acta Diabetol. 2017;54(5):417–424. doi:10.1007/s00592-017-0970-528210868
   PubMed Web of Science ®Google Scholar
• Sundstrom JM, Hernández C, Weber S, et al. Proteomic analysis of early diabetic retinopathy reveals mediators of neurodegenerative brain diseases. Invest Ophthamol Vis Sci. 2018;59(6):2264–2274. doi:10.1167/iovs.17-23678
   PubMed Web of Science ®Google Scholar
• Kirbas S, Turkyilmaz K, Tufekci A, Durmus M. Retinal nerve fiber layer thickness in Parkinson’s disease. J Neuroophthalmol. 2013;33(1):62–65. doi:10.1097/WNO.0b013e318270174523100041
   PubMed Web of Science ®Google Scholar
• Altintas Ö, Iseri P, Ozkan B, Caglar Y. Correlation between retinal morphological and functional findings and clinical severity in Parkinson’s disease. Doc Ophthalmol. 2008;116(2):137–146. doi:10.1007/s10633-007-9091-817962989
   PubMed Web of Science ®Google Scholar
• Inzelberg R, Ramirez JA, Nisipeanu P, Ophir A. Retinal nerve fiber layer thinning in Parkinson’s disease. Vision Res. 2004;44(24):2793–2797. doi:10.1016/j.visres.2004.06.00915342223
   PubMed Web of Science ®Google Scholar
• La Morgia C, Barboni P, Rizzo G, et al. Loss of temporal retinal nerve fibers in Parkinson’s disease: a mitochondrial pattern? Eur J Neurol. 2013;20(1):198–201. doi:10.1111/j.1468-1331.2012.03701.x22436028
   PubMed Web of Science ®Google Scholar
• Garcia-Martin E, Larrosa JM, Polo V, et al. Distribution of retinal layer atrophy in patients with Parkinson’s disease and association with disease severity and duration. Am J Ophthalmol. 2014;157(2):470–478. doi:10.1016/j.ajo.2013.09.02824315296
   PubMed Web of Science ®Google Scholar
• Jimenez B, Ascaso FJ, Cristobal JA, Lopez Del Val J. Development of a prediction formula of Parkinson’s disease severity by optical coherence tomography. Mov Disord. 2014;29(1):68–74. doi:10.1002/mds.2574724458320
   PubMed Web of Science ®Google Scholar
• Aaker GD, Myung JS, Ehrlich JR, Mohammed M, Henchcliffe C, Kiss S. Detection of retinal changes in Parkinson’s disease with spectral-domain optical coherence tomography. Clin Ophthalmol. 2010;6(4):1427–1432.
   Google Scholar
• Archibald NK, Clarke MP, Mosimann UP, Burn DJ. Retinal thickness in Parkinson’s disease. Parkinsonism Relat Disord. 2011;17(6):431–436. doi:10.1016/j.parkreldis.2011.03.00421454118
   PubMed Web of Science ®Google Scholar
• Yu J-G, Feng Y-F, Xiang Y, et al. Retinal nerve fiber layer thickness changes in Parkinson disease: a meta-analysis. PLoS One. 2014;9(1):e85718. doi:10.1371/journal.pone.008571824465663
   PubMed Web of Science ®Google Scholar
• Garcia-Martin E, Rodriguez-Mena D, Satue M, et al. Electrophysiology and optical coherence tomography to evaluate Parkinson’s disease severity. Invest Ophthalmol Vis Sci. 2014;55(2):696–705. doi:10.1167/iovs.13-1306224425856
   PubMed Web of Science ®Google Scholar
• Shrier EM, Adam CR, Spund B, Glazman S, Bodis-Wollner I. Interocular asymmetry of foveal thickness in Parkinson’s disease. J Ophthalmol. 2012;2012:728457. doi:10.1155/2012/72845722900149
   PubMed Web of Science ®Google Scholar
• Cubo E, Tedejo RP, Rodriguez Mendez V, Lopez Pena MJ, Trejo Gabriel YGJM. Retina thickness in Parkinson’s disease and essential tremor. Mov Disord. 2010;25:2461–2462. doi:10.1002/mds.2321520669291
   PubMed Web of Science ®Google Scholar
• Spund B, Ding Y, Liu T, et al. Remodeling of the fovea in Parkinson’s disease. J Neural Transm. 2013;120(5):745–753. doi:10.1007/s00702-012-0909-523263598
   PubMed Web of Science ®Google Scholar
• Albrecht P, Muller A-K, Sudmeyer M, et al. Optical coherence tomography in parkinsonian syndromes. PLoS One. 2012;7(4):e34891. doi:10.1371/journal.pone.003489122514688
   PubMed Web of Science ®Google Scholar
• Schneider M, Muller H-P, Lauda F, et al. Retinal single-layer analysis in parkinsonian syndromes: an optical coherence tomography study. J Neural Transm. 2014;121(1):41–47. doi:10.1007/s00702-013-1072-323907408
   PubMed Web of Science ®Google Scholar
• Satue M, Obis J, Alarcia R, et al. Retinal and choroidal changes in patients with Parkinson’s disease detected by swept-source optical coherence tomography. Curr Eye Res. 2018;43(1):109–115. doi:10.1080/02713683.2017.137011629111842
   PubMed Web of Science ®Google Scholar
• Kwapong WR, Ye H, Peng C, et al. Retinal microvascular impairment in the early stages of Parkinson’s disease. Invest Ophthalmol Vis Sci. 2018;;59(10):4115–4122. doi:10.1167/iovs.17-2323030098201
   PubMed Web of Science ®Google Scholar
• Litvan I, Mangone CA, McKee A, et al. Natural history of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) and clinical predictors of survival: a clinicopathological study. J Neurol Neurosurg Psychiatry. 1996;60:615–620. doi:10.1136/jnnp.60.6.6158648326
   PubMed Web of Science ®Google Scholar
• Mendoza-Santiesteban C, Gabilondo I, Palma JA, Norcliffe-Kaufmann L, Kaufmann H. The retina in multiple system atrophy: systematic review and meta-analysis. Front Neurol. 2017;24(8):206. doi:10.3389/fneur.2017.00206
   Web of Science ®Google Scholar
• Ahn J, Lee JY, Kim TW. Retinal thinning correlates with clinical severity in multiple system atrophy. J Neurol. 2016;263:2039–2047. doi:10.1007/s00415-016-8230-027416856
   PubMed Web of Science ®Google Scholar
• Mendoza-Santiesteban CE, Palma JA, Martinez J, Norcliffe-Kaufmann L, Hedges RT 3rd, Kaufmann H. Progressive retinal structure abnormalities in multiple system atrophy. Mov Disord. 2015;30:1944–1953. doi:10.1002/mds.2636026359930
   PubMed Web of Science ®Google Scholar
• Jellinger KA, Seppi K, Wenning GK. Grading of neuropathology in multiple system atrophy: proposal for a novel scale. Mov Disord. 2005;20(Suppl 12):S29–S36. doi:10.1002/mds.2053716092088
   PubMed Web of Science ®Google Scholar
• Joutel A, Corpechot C, Ducros A, et al. Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and Dementia. Nature. 1996;383(6602):707–710. doi:10.1038/383707a08878478
   PubMed Web of Science ®Google Scholar
• Tikka S, Mykkanen K, Ruchoux MM, et al. Congruence between NOTCH3 mutations and GOM in 131 CADASIL Patients. Brain. 2009;132(Pt 4):933–939. doi:10.1093/brain/awn36419174371
   PubMed Web of Science ®Google Scholar
• Nelis P, Kleffner I, Burg M, et al. OCT-angiography reveals reduced vessel density in the deep retinal plexus of CADASIL patients. Sci Rep. 2018;25(8):8148. doi:10.1038/s41598-018-26475-5
   Web of Science ®Google Scholar
• Alten F, Motte J, Ewering C, et al. Multimodal retinal vessel analysis in CADASIL patients. PLoS One. 2014;5(9):e112311. doi:10.1371/journal.pone.0112311
   Web of Science ®Google Scholar
• Haritoglou C, Hoops J, Stefani F, Mehraein P, Kampik A, Dichgans M. Histopathological abnormalities in ocular blood vessels of CADASIL patients. Am J Ophthalmol. 2004;138(2):302–305. doi:10.1016/j.ajo.2004.02.07315289148
   PubMed Web of Science ®Google Scholar
• Fang JX, Yu M, Wu Y, et al. Study of enhanced depth imaging optical coherence tomography in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Chin Med J (Engl). 2017;130:1042–1048. doi:10.4103/0366-6999.20493528469098
   PubMed Web of Science ®Google Scholar
• Wijesekera LC, Leigh PN. Amyotrophic lateral sclerosis. Orphanet J Rare Dis. 2009;4(1):3. doi:10.1186/1750-1172-4-319192301
   PubMed Web of Science ®Google Scholar
• Simonett JCJ, Siddique N, Armstrong JL, Fawzi AA, Siddique T, Volpe NJ. Ocular Manifestations and Optic Nerve Changes in Patients with Amyotrophic Lateral Sclerosis (ALS). ARVO; 2013.
   Google Scholar
• Mukherjee N, McBurney-Lin S, Kuo A, Bedlack R, Tseng H, Bhattacharya S. Retinal thinning in amyotrophic lateral sclerosis patients without ophthalmic disease. PLoS One. 2017;12(9):e0185242. doi:10.1371/journal.pone.018524228945811
   PubMed Web of Science ®Google Scholar
• Rohani M, Meysamie A, Zamani B, Sowlat MM, Akhoundi FH. Reduced retinal nerve fiber layer (RNFL) thickness in ALS patients: a window to disease progression. J Neurol. 2018;265(7):1557–1562. doi:10.1007/s00415-018-8863-229713825
   PubMed Web of Science ®Google Scholar
• Simonett JM, Huang R, Siddique N, et al. Macular sub-layer thinning and association with pulmonary function tests in amyotrophic lateral sclerosis. Sci. Rep. 2016;6(1):29187. doi:10.1038/srep2918727383525
   PubMed Web of Science ®Google Scholar
• Hübers A, Müller HP, Dreyhaupt J, et al. Retinal involvement in amyotrophic lateral sclerosis: a study with optical coherence tomography and diffusion tensor imaging. J. Neural Transm. 2016;123(3):281–287. doi:10.1007/s00702-015-1483-426582428
   PubMed Web of Science ®Google Scholar
• Volpe NJ, Simonett J, Fawzi AA, Siddique T. Opthalmic manifestations of amyotrophic lateral sclerosis (an American ophthalmological society thesis). Trans Am Ophthalmol Soc. 2015;113:1–15.
   Google Scholar
• Mukherjee NKA, Bedlack R, Tseng H. Imaging Amyotrophic Lateral Sclerosis (ALS) Neurodegeneration Through the Eye. Orlando, Florida: ARVO; 2014.
   Google Scholar
• Roth NM, Saidha S, Zimmermann H, et al. Optical coherence tomography does not support optic nerve involvement in amyotrophic lateral sclerosis. Eur J Neurol. 2013;20(8):1170–1176. doi:10.1111/ene.1214623582075
   PubMed Web of Science ®Google Scholar
• Rojas P, de Hoz R, Ramirez IA, et al. Changes in retinal OCT and their correlations with neurological disability in early ALS patients, a follow-up study. Brain Sci. 2019;9(12):337. doi:10.3390/brainsci9120337
   PubMed Web of Science ®Google Scholar
• Cerveró A, Casado A, Riancho J. Retinal changes in amyotrophic lateral sclerosis: looking at the disease through a new window. J Neurol. 2019;2. doi:10.1007/s00415-019-09654-w
   Web of Science ®Google Scholar
• McColgan P, Tabrizi SJ. Huntington’s disease: a clinical review. Eur J Neurol. 2018;25(1):24–34. doi:10.1111/ene.1341328817209
   PubMed Web of Science ®Google Scholar
• Kersten HM, Danesh-Meyer HV, Kilfoyle DH, Roxburgh RH. Optical coherence tomography findings in huntington’s disease: a potential biomarker of disease progression. J Neurol. 2015;262:2457–2465. doi:10.1007/s00415-015-7869-226233693
   PubMed Web of Science ®Google Scholar
• Andrade C, Beato J, Monteiro A, et al. Spectral-domain optical coherence tomography as a potential biomarker in huntington’s disease. Mov Disord. 2016;31:377–383. doi:10.1002/mds.2648626853218
   PubMed Web of Science ®Google Scholar
• Gatto E, Parisi V, Persi G, et al. Optical Coherence Tomography (OCT) study in argentinean huntington’s disease patients. Int J Neurosci. 2018;128(12):1157–1162. doi:10.1080/00207454.2018.148980729912591
   PubMed Web of Science ®Google Scholar
• Wylęgała A. Principles of OCTA and applications in clinical neurology. Curr Neurol Neurosci Rep. 2018;18:96. doi:10.1007/s11910-018-0911-x30338429
   PubMed Web of Science ®Google Scholar
• Asanad S, Wu J, Nassisi M, Ross-Cisneros NF, Sadun AA. Optical coherence tomography-angiography in Wolfram syndrome: a mitochondrial etiology in disease pathophysiology. Can J Ophthalmol. 2019;54:e27–e30. doi:10.1016/j.jcjo.2018.04.00230851792
   PubMed Web of Science ®Google Scholar
• Parrozzani R, Leonardi F, Frizziero L, et al. Retinal vascular and neural remodeling secondary to optic nerve axonal degeneration. Ophthalmol Retin. 2018;2(8):827–835. doi:10.1016/j.oret.2017.12.001
   Google Scholar
• Chang MY, Phasukkijwatana N, Garrity S, et al. Foveal and peripapillary vascular decrement in migraine with aura demonstrated by optical coherence tomography angiography. Invest Ophthalmol Vis Sci. 2017;58(12):5477–5484. doi:10.1167/iovs.17-2247729059314
   PubMed Web of Science ®Google Scholar
• Ulusoy M, Horasanli B, Kal A. Retinal vascular density evaluation of migraine patients with and without aura and association with white matter hyperintensities. Acta Neurol Belg. 2019;119(3):411–417. doi:10.1007/s13760-019-01094-730762208
   PubMed Web of Science ®Google Scholar
• Tasli GN, Ersoy A. Altered macular vasculature in migraine patients without aura: is it associated with ocular vasculature and white matter hyperintensities? J Ophthalmol. 2020;13(2020):3412490.
   Google Scholar
• Grewal DS, Fine HF, Fekrat S. Is OCT angiography useful in neurodegenerative diseases? Ophthalmic Surg Lasers Imaging Retina. 2019;50(5):269–273. doi:10.3928/23258160-20190503-0231100156
   PubMedGoogle Scholar